Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$618,679
-$74,498 QoQ
Shares Held
3,248
-11.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,243
of 2,066 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fi3 FINANCIAL ADVISORS, LLC holds $3,052,200 across 6 Diagnostics & Research names. DHR ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,340 | $671,822 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
3,248 | $618,679 | |
| 3 | NTRA |
Natera, Inc.
|
2,105 | $571,402 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,292 | $437,276 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
810 | $428,967 | |
| 6 | ILMN |
Illumina, Inc.
|
1,843 | $324,054 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,679 | 3,248 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $693,177 | 3,656 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $401,067 | 1,752 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $284,304 | 1,434 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $241,591 | 1,223 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||